Editorial: Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease (GVHD)

Editorial: Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease (GVHD)

Bibliographic Details
Main Authors:	Evelyn Ullrich, Andreas Beilhack, Dietlinde Wolf
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Immunology
Subjects:	allogeneic hematopoietic stem cell transplantation (aHSCT) acute and chronic graft versus host disease (a/c GVHD) GVL metabolism microbiome cell therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.966389/full

Similar Items

T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
by: Julia Campe, et al.
Published: (2022-01-01)

Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review
by: Abhinav Bhattarai, et al.
Published: (2024-12-01)

mTOR Signaling Regulates the Development and Therapeutic Efficacy of PMN-MDSCs in Acute GVHD
by: Xiaoqing Li, et al.
Published: (2021-12-01)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
by: Mehrdad Hefazi, et al.
Published: (2021-09-01)

Impact of oral microbiota on pathophysiology of GVHD
by: Akira Yamamoto, et al.
Published: (2023-03-01)

Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft‐Versus‐Host Disease
by: Huidong Guo, et al.
Published: (2022-07-01)

Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series
by: Ashley N. Gray, et al.
Published: (2023-05-01)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
by: Takahide Ara, et al.
Published: (2021-08-01)

Dysregulated Expression of CD28 and CTLA-4 Molecules in Patients with Acute Myeloid Leukemia and Possible Association with Development of Graft <em>versus</em> Host Disease after Hematopoietic Stem Cell Transplantation
by: M Ramzi, et al.
Published: (2019-05-01)

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
by: Nancy Y. Villa, et al.
Published: (2016-03-01)

The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
by: Sandeep Kumar, et al.
Published: (2018-12-01)

Immune reconstitution after hematopoietic stem cell transplantation
by: Justyna Ogonek, et al.
Published: (2016-11-01)

Novel therapies for graft versus host disease with a focus on cell therapies
by: Robert Zeiser, et al.
Published: (2023-10-01)

The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
by: Robert Puckrin, et al.
Published: (2023-01-01)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
by: Elizabeth Stenger, et al.
Published: (2022-09-01)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
by: Christos Demosthenous, et al.
Published: (2021-05-01)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
by: M. Faraci, et al.
Published: (2024-03-01)

CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model
by: Ji-Young Lim, et al.
Published: (2020-06-01)

Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
by: Mette Jørgensen, et al.
Published: (2022-09-01)

Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
by: Ryo Hanaki, et al.
Published: (2021-12-01)

“Is this the GVHD?” A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service
by: Isabella de Vere Hunt, et al.
Published: (2021-01-01)

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation
by: Farnsworth Paul, et al.
Published: (2012-09-01)

Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease
by: Xinyi Zhou, et al.
Published: (2020-04-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
by: Delaney Wolfe, et al.
Published: (2021-11-01)

Legionella pneumophila Subspecies fraseri Infection after Allogeneic Hematopoietic Stem Cell Transplant, China
by: Xiaojuan Wang, et al.
Published: (2022-04-01)

Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease
by: Diana M. Matthe, et al.
Published: (2023-08-01)

Research progress of endothelial injury in the development of graft-versus-host disease
by: LU Wenqi, WAN Lin
Published: (2023-11-01)

Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Crocchiolo Roberto, et al.
Published: (2021-02-01)

Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population
by: Said Chaaban, et al.
Published: (2023-05-01)

Janus kinase inhibition in the treatment and prevention of graft-versus-host disease
by: Elisa De Togni, et al.
Published: (2024-02-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

Follicular graft-versus-host disease: A rare manifestation in a patient with the overlap subtype of chronic graft-versus-host disease
by: Yi-Hsin Ho, et al.
Published: (2019-01-01)

Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity
by: Qingxiao Song, et al.
Published: (2022-05-01)

Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease
by: Kristy E. Gilman, et al.
Published: (2023-01-01)

Alloreactivity of virus-specific T cellsPossible implication of graft-versus-host disease and graft-versus-leukemia effects
by: Shigeo eFuji, et al.
Published: (2013-10-01)

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies
by: Felicitas Schulz, et al.
Published: (2024-01-01)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-09-01)